Biopharmaceuticals sector's rapid expansion, and the growing use of chromatography in the purification of monoclonal antibodies is expected to augment the growth of liquid chromatography for biopharma

calendar_today 29 July, 2022 person_outline Growth Plus Reports

Liquid Chromatography for Biopharmaceuticals Market by Technique (High-Pressure Liquid Chromatography (HPLC), Low-Pressure Liquid Chromatography (LPLC), Ultra-High-Pressure Liquid Chromatography (UHPLC)/Ultra-Performance Liquid Chromatography (UPLC), Fast Protein Liquid Chromatography (FPLC)), Type (Instruments, Consumables, Software & Accessories], End User [Pharmaceutical Companies, Academics and Research Institutes, Contract Research Organizations] – Global Outlook & Forecast 2022-2030

According to the deep-dive market assessment study conducted by Growth Plus Reports, the globalliquid chromatography for biopharmaceuticals market was pegged at US$ 6,330.1 million in 2021. The market is expected to witness a CAGR of 5.7% from 2022 to 2030.

The market for liquid chromatography for biopharmaceuticals is primarily driven by the biopharmaceuticals sector's rapid expansion, the growing use of chromatography in the purification of monoclonal antibodies, and advances in liquid chromatography technology. The expensive cost of the equipment and the scarcity of qualified professionals, however, are anticipated to limit market expansion to some extent.

Biopharmaceutical industry is valued at over US$ 400 billion and is anticipated to further progress at a healthy rate of growth, where the biopharmaceutical revenue and therefore the R&D investments within the field are anticipated to grow at a rate of roughly 12%. Thus, the consistent and powerful growth of the sphere is fueling the trends in liquid chromatography for the biopharmaceuticals market. The expansion of this market is indicated by trends like growing approvals of brands for new indications, and evolution of cell & gene therapies.

Monoclonal antibodies capture a large share in the global liquid chromatography for biopharmaceuticals industry. The consistent growth in the biopharmaceuticals pipeline has further surged the demand for high throughput methods of analysis. The UHPLC technique has also been successfully developed to improve the resolution of separation and further decrease analysis time. The latest technological development in the UHPLC technique has also made it useful in the analysis of large antibodies such as monoclonal antibodies. Hence, these factors will collectively ensure augmented productivity and thus drive the global liquid chromatography market for biopharmaceuticals.

Several advancements have also been witnessed in the field of chromatography. For instance, the introduction of highly efficient columns for biopharmaceutical analysis and the advent of instrumentation for performing analysis on these columns have enabled the rapid introduction of biotherapeutics in the market. Technologies such as UHPLC have continued to deliver better separations and are now better understood through the field of biopharmaceutical development and are hence enjoying an incumbent position.

Operational complications in these techniques especially LC instruments and consumables manufacturers in biotech companies and limited experience in clinical development, and the presence of insufficient infrastructure of small biopharmaceutical companies is limiting the demand of analytical tools thus restricting the overall liquid chromatography market.

Asia Pacific is witnessing an incredible growth because of the innovations and investments in this region. The refurnished R&D activities during the Covid-19 pandemic has attracted several investors in the biopharma sector. Thus, Asia Pacfic market is mainly driven by investments and support by the government and clincal research initiatives in China, Japan and India. Increased production of biopharmaceuticals in Japan is creating further opportunities for other countries in APAC region. The growing healthcare expenditure in the Asia Pacific is also estimated to develop lucrative growth opportunities for liquid chromatography for biopharmaceuticals market.

Some of the prominent players operating in the liquid chromatography for biopharmaceuticals market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Merck KGaA, Waters Corporation, Bio-Rad Laboratories, Inc., Tosoh Bioscience LLC, Metrohm AG, Danaher Corporation, Shimadzu Corporation, among others

awards awards key differentiators

Reach Us

Web –

// // // //